| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4031129 | Ophthalmology | 2006 | 11 Pages |
Abstract
The safety and efficacy outcomes in this study demonstrate that the benefits of anecortave acetate for the treatment of choroidal neovascularization outweigh the risks associated with either the drug or the PJD administration procedure.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jason S. MD, Thomas MD, MPH, Donald J. MD, Bethany PhD, Janice PhD, E. Kenneth PhD, Anecortave Acetate Clinical Study Group Anecortave Acetate Clinical Study Group,